CoChat

The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases

Open access
Ubeda-Bañon, Isabel, Saiz-Sanchez, Daniel, Flores-Cuadrado, Alicia, Rioja-Corroto, Ernesto, Gonzalez-Rodriguez, Melania, Villar-Conde, Sandra, Astillero-Lopez, Veronica, Cabello-de la Rosa, Juan Pablo, Gallardo-Alcañiz, Maria Jose, Vaamonde-Gamo, Julia, Relea-Calatayud, Fernanda, Gonzalez-Lopez, Lucia, Mohedano-Moriano, Alicia, Rabano, Alberto, Martinez-Marcos, Alino · 2020 · Translational Neurodegeneration
Cited by 123

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Alzheimer’s and Parkinson’s diseases are the most prevalent neurodegenerative disorders. Their etiologies are idiopathic, and treatments are symptomatic and orientated towards cognitive or motor deficits. Neuropathologically, both are proteinopathies with pathological aggregates (plaques of amyloid-β peptide and neurofibrillary tangles of tau protein in Alzheimer’s disease, and Lewy bodies mostly composed of α-synuclein in Parkinson’s disease). These deposits appear in the nervous system in a predictable and accumulative sequence with six neuropathological stages. Both disorders present a long prodromal period, characterized by preclinical signs including hyposmia. Interestingly, the olfactory system, particularly the anterior olfactory nucleus, is initially and preferentially affected by the pathology. Cerebral atrophy revealed by magnetic resonance imaging must be complemented by histological analyses to ascertain whether neuronal and/or glial loss or neuropil remodeling are responsible for volumetric changes. It has been proposed that these proteinopathies could act in a prion-like manner in which a misfolded protein would be able to force native proteins into pathogenic folding (seeding), which then propagates through neurons and glia (spreading). Existing data have been examined to establish why some neuronal populations are vulnerable while others are resistant to pathology and to what extent glia prevent and/or facilitate proteinopathy spreading. Connectomic approaches reveal a number of hubs in the olfactory system (anterior olfactory nucleus, olfactory entorhinal cortex and cortical amygdala) that are key interconnectors with the main hubs (the entorhinal–hippocampal–cortical and amygdala–dorsal motor vagal nucleus) of network dysfunction in Alzheimer’s and Parkinson’s diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40035-020-00200-7

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Cited by

See all 123

Metadata

Authors
Ubeda-Bañon, I., Saiz-Sanchez, D., Flores-Cuadrado, A., Rioja-Corroto, E., Gonzalez-Rodriguez, M., Villar-Conde, S., Astillero-Lopez, V., Cabello-de la Rosa, J. P., Gallardo-Alcañiz, M. J., Vaamonde-Gamo, J., Relea-Calatayud, F., Gonzalez-Lopez, L., Mohedano-Moriano, A., Rabano, A., & Martinez-Marcos, A.
Venue
Translational Neurodegeneration
Published
2020-06-03
Volume
9
Issue
1
Pages
22-22
ISSN
2047-9158 (ISSN-L)
OpenAlex
W3032289835
Cited by
123
References
47
FWCI
4.49
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases. https://app.cochat.ai/papers/10.1186/s40035-020-00200-7
The paper
Ubeda-Bañon, I., Saiz-Sanchez, D., Flores-Cuadrado, A., Rioja-Corroto, E., Gonzalez-Rodriguez, M., Villar-Conde, S., Astillero-Lopez, V., Cabello-de la Rosa, J. P., Gallardo-Alcañiz, M. J., Vaamonde-Gamo, J., Relea-Calatayud, F., Gonzalez-Lopez, L., Mohedano-Moriano, A., Rabano, A., & Martinez-Marcos, A. (2020). The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases. Translational Neurodegeneration. https://doi.org/10.1186/s40035-020-00200-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.